Not a registered adviser. Posts are commentary, not investment advice.
Joined April 2022
- Tweets 2,772
- Following 90
- Followers 2,690
- Likes 1
398 Photos and videos
Pinned Tweet
$OTLK
OTLK’s journey reaches its defining moment. FDA has accepted the resubmitted BLA — positioning Outlook Therapeutics for first‑in‑class approval and a potential $600M–$1.2B valuation window.
sites.google.com/view/outloo…
2
226
$CNCT Huge insider buy
CHEETAH NET SUPPLY CHAIN SERVICE INC.: Liu Huan (Director, See Remarks, 10% ) Buys 200,000 @ Avg Price: $2.00 (Form4)
97
Jun 17
$SRXH When the merger was announced this ran to .60
Eric Jackson directly posted about it on X, sharing a Reuters article titled "EMJ's Jackson pursues crypto treasury strategy with reverse merger" (Dec 17, 2025).
@ericjackson
reuters.com/sustainability/s…
1
5
907
Jun 16
$OTLK Holding through the run up to July 29 FDA date...
could see $5.00 by then in my opinion...I believe the market has concluded FDA approval is imminent... analyst upgraded price target to $10 on BLA submission today.
1
7
1,679
Jun 16
$OTLK
Ascendiant Capital — Buy, price target raised from $6 → $10
confirms the FDA accepted the resubmitted BLA and set a PDUFA target action date of July 29 2026, which underpins Ascendiant’s upgrade
2
326
Jun 16
$SRXH- If SEC rules on merger this week and filings start to drop this might explode on Eric Jackson taking over as CEO and Chairman.
1
4
22
1,469
Jun 16
$OTLK BLA submitted
FDA approval is the inflection point. OTLK becomes the first on‑label ophthalmic bevacizumab in the U.S.
— unlocking a $600M–$1.2B valuation window.
De‑risked. First‑to‑market. Strong economics.
1
393
Jun 16
$SRXH
Upon the closing of the merger, Jackson is slated to step in as Chief Executive Officer and Chairman of the combined company
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
theglobeandmail.com/investin…
5
13
2,530
Jun 16
$OTLK- BLA submitted- 1-60 days for FDA to rule
There is a very good chance of approval here
1
301
Jun 15
$CYCL A clean, debt‑free public vehicle now positioned for a transformative AI‑Robotics acquisition. No dilution. No toxic debt. No legacy baggage. A rare OTC structure built for scale — and a pending merger that could redefine its footprint.
sites.google.com/view/cyclcy…
1
2
227
Jun 15
$CYCL CEO released acquisition PR on the weekend for California AI Robotics company...then posted this following day.
Seems he is in San Fran to close the deal perhaps.
There is a company that fits the description he laid out in PR...that company is Agtonomy
1
3
5
361
Jun 15
$CYCL CEO Nugent has arrived in San Francisco presumably to procure an AI Robotics acquisition with global reach.
PR released June 13
stocktitan.net/news/CYCL/cyc…
x.com/MichealNugent22
1
1
4
355
Jun 15
$SRXH Eric Jackson is slated to become CEO and Chairman of the merged SRx Health and his crypto company EMJX
Deadline for target milestones is June 15
@ericjackson
1
9
1,393
Jun 15
$SRXH
EMJ Crypto Technologies entered into a definitive agreement to acquire SRx Health Solutions Inc. in a reverse merger Eric Jackson is set to head a crypto treasury firm following a reverse merger with SRx SRXH canceling 125M shares of common stock in balance sheet cleanup
2
14
1,463
Jun 15
$SRXH The merger between SRx Health Solutions (NYSE American: SRXH) and Eric Jackson's EMJ Crypto Technologies (EMJX) is expected to officially close on June 15, 2026. [1]
5
38
8,595
Jun 14
OTC Merger
Company has no toxic debt or warrants outstanding, no ATM, no shelf or equity line..no dilution in years.
94% owned by CEO
Low float
x.com/deepblueequity/status/…
Jun 14
Potential for a big merger developing in the OTC markets- stay tuned
1
249